Background Increased blood pressure is the biggest contributor to the global burden of
disease and mortality. Data suggest that less than half of the population with hypertension is …

Compounds 1–18 have been synthesized and tested in vitro against the protozoa Giardia
lamblia, Entamoeba histolytica and the helminth Trichinella spiralis. Inhibition of rat brain …

2-(Trifluoromethyl)benzimidazole derivatives substituted at the 1-, 5-, and 6-positions have
been synthesized and in vitro tested against the protozoa Giardia lamblia, Entamoeba …

Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden
worldwide and fewer than half of those with hypertension are aware of it. May Measurement …

Introduction: Nanocarriers have emerged as a powerful alternative for cancer therapy. Indeed,
they are promising candidates to tackle the acquired resistance of surviving cells against …

Introduction Mesoporous silica nanoparticles (MSNs) are outstanding nanoplatforms for drug
delivery. Herein, the most recent advances to turn MSN-based carriers into minimal side …

The enormous versatility of mesoporous silica nanoparticles permits the creation of a large
number of nanotherapeutic systems for the treatment of cancer and many other pathologies. …

A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives (1a–1i) were synthesized via
Phillips cyclocondensation of a substituted 1,2-phenylenediamine and trifluoroacetic acid. The …

Abstract Treatment for coronavirus disease 2019 (COVID19) pneumonia remains empirical
and the search for therapies that can improve outcomes continues. Melatonin has been …

A series of 2-(trifluoromethyl)-1H-benzimidazole derivatives with various 5- and 6-position
bioisosteric substituents (–Cl, –F, –CF 3 , –CN), namely 1–7, were prepared using a short …